✦ LIBER ✦

Acute graft versus host disease after non-myeloablative allogeneic stem cell transplantation (NST) with low-dose TBI, fludarabine and antithymocyte globulin (ATG)

✍ Scribed by C.L. Grosskreutz; E. Scigliano; S.M. Fruchtman; L.M. Isola

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

295: Graft versus host disease after ste

✍ C.L. Grosskreutz; E. Scigliano; K. Osman; L.M. Isola 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Successful Prevention of Acute Graft-ver

✍ Hee-Je Kim; Woo-Sung Min; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Chang-Ki Min 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 509 KB

High Rates of Non-Relapse Mortality and

✍ A.S. Kanate; L. Chaudhary; A. Cumpston; S. Leadmon; P. Bunner; D. Bulian; L. Gib 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Pulmonary complications after T-cell-dep

✍ Huisman, C; van der Straaten, H M; Canninga-van Dijk, M R; Fijnheer, R; Verdonck 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Low-dose alemtuzumab (Campath®) in myelo

✍ Khouri, I F; Albitar, M; Saliba, R M; Ippoliti, C; Ma, Y C; Keating, M J; Champl 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Prophylaxis with Sirolimus and Tacrolimu

✍ Lindsay L. Rosenbeck; Patrick J. Kiel; Iftekhar Kalsekar; Craig Vargo; John Baut 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB